Arash Hatefi

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Top Venues

Medical oncology (Northwood, London, England)

Journal for immunotherapy of cancer

Antibodies (Basel, Switzerland)

Biomacromolecules

This page only lists publications with an associated author ORCID identifier.

Publications

Shahryar Khoshtinat Nikkhoi, Ge Yang, Hajar Owji, Mayara Grizotte-Lake, Rick I Cohen, Lazaro Gil Gonzalez, Mohammad Massumi, Arash Hatefi
Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice. Journal for immunotherapy of cancer 12 (3) (2024)
Ge Yang, Shahryar Khoshtinat Nikkhoi, Hajar Owji, Geng Li, Mohammad Massumi, Jessica Cervelli, Venu Gopal Vandavasi, Arash Hatefi
A Novel Tetravalent Bispecific Immune Cell Engager Activates Natural Killer Cells to Kill Cancer Cells without Mediating Fratricide. Antibodies (Basel, Switzerland) 13 (3) (2024)
Shahryar Khoshtinat Nikkhoi, Ge Yang, Hajar Owji, Mayara Grizotte-Lake, Rick I Cohen, Lazaro Gil Gonzalez, Mohammad Massumi, Arash Hatefi
Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice. Journal for immunotherapy of cancer 12 (3) (2024)
Shahryar Khoshtinat Nikkhoi, Ge Yang, Hajar Owji, Mayara Grizotte-Lake, Rick I Cohen, Lazaro Gil Gonzalez, Mohammad Massumi, Arash Hatefi
Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice. Journal for immunotherapy of cancer 12 (3) (2024)
Shahryar Khoshtinat Nikkhoi, Ge Yang, Hajar Owji, Mayara Grizotte-Lake, Rick I Cohen, Lazaro Gil Gonzalez, Mohammad Massumi, Arash Hatefi
Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice. Journal for immunotherapy of cancer 12 (3) (2024)
Shahryar Khoshtinat Nikkhoi, Hediyeh Heydarzadeh, Venu Gopal Vandavasi, Ge Yang, Pedro Louro, Marianne Polunas, Hajar Owji, Arash Hatefi
A high affinity and specificity anti-HER2 single-domain antibody (VHH) that targets trastuzumab's epitope with versatile biochemical, biological, and medical applications. Immunologic research (2023)
Geng Li, Shahryar Khoshtinat Nikkhoi, Arash Hatefi
Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands. Medical oncology (Northwood, London, England) 40 (4) (2023)
Geng Li, Shahryar Khoshtinat Nikkhoi, Arash Hatefi
Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands. Medical oncology (Northwood, London, England) 40 (4) (2023)
Geng Li, Shahryar Khoshtinat Nikkhoi, Arash Hatefi
Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands. Medical oncology (Northwood, London, England) 40 (4) (2023)
Geng Li, Shahryar Khoshtinat Nikkhoi, Arash Hatefi
Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands. Medical oncology (Northwood, London, England) 40 (4) (2023)
Siddik Sarkar, Obeid M Malekshah, Alireza Nomani, Niket Patel, Arash Hatefi
A novel chemotherapeutic protocol for peritoneal metastasis and inhibition of relapse in drug resistant ovarian cancer. Cancer medicine 7 (8) (2018)
Arash Hatefi, Zahra Karjoo, Alireza Nomani
Development of a Recombinant Multifunctional Biomacromolecule for Targeted Gene Transfer to Prostate Cancer Cells. Biomacromolecules 18 (9) (2017)